Iridex (IRIX) Common Equity (2011 - 2026)

Iridex's Common Equity history runs 16 years deep, the most recent figure standing at $4.7 million for Q2 2026.

• On a quarterly basis, Common Equity rose 455.4% year-over-year to $4.7 million in Q2 2026; TTM through Apr 2026 was $4.7 million, a 455.4% increase from a year earlier, with the FY2026 full-year figure at $4.9 million, up 134.72% from the prior year.
• Common Equity declined to $4.7 million in Q2 2026 per IRIX's latest filing, from $4.9 million in the prior quarter.
• Across five years, Common Equity topped out at $23.3 million in Q1 2022 and bottomed at $852000.0 in Q1 2025.
• The 5-year median for Common Equity is $8.0 million (2023), against an average of $10.4 million.
• Across the five-year window, Common Equity plunged 86.87% in 2025 and soared 455.4% in 2026, its largest moves.
• Year by year, Common Equity stood at $17.2 million in 2022, then sank by 44.74% to $9.5 million in 2023, then slumped by 77.98% to $2.1 million in 2024, then soared by 123.22% to $4.7 million in 2025, then increased by 1.09% to $4.7 million in 2026.
• Per Business Quant, the three latest IRIX Common Equity figures stand at $4.7 million (Q2 2026), $4.9 million (Q1 2026), and $4.7 million (Q3 2025).